Recent CNIC News
The Canadian Nuclear Isotope Council to partner with D-Pace to increase collaboration across Canada’s entire isotope supply chain
Toronto – September 19 2023 – The Canadian Nuclear Isotope Council (CNIC) is excited to announce that D-Pace, a supplier of products and services to the Canadian and international commercial...
Megalab Group Inc. joins the CNIC to bring essential product testing to the Canadian isotope production pipeline
Toronto – September 18, 2023 – Megalab Group Inc., a one-stop-shop laboratory for product safety validation, environmental testing, and regulatory compliance based in Aurora, ON, has joined the...
New CNIC report emphasizes that the importance of sufficient labour to support innovation in Canada’s isotope supply chain
Toronto – July 24th , 2023 – The Canadian Nuclear Isotope Council (CNIC) has released a new report that shows the importance of sufficient and well-trained talent to support the Canadian isotope...
The Government of Canada to invest in the Canadian Medical Isotope Ecosystem through the Strategic Innovation Fund
Bruce County – June 27, 2023 – Today, the Government of Canada signalled its support for the medical isotope industry with a significant investment through the Strategic Innovation Fund (SIF) under...
The Southwestern Ontario Isotope Coalition joins the Canadian Nuclear Isotope Council with the common goal of supporting life-saving isotope production
Owen Sound, ON – The Southwestern Ontario Isotope Coalition, a partnership between regional leaders including the City of Owen Sound and the Nuclear Innovation Institute (NII) enabled by the ...
Canadian Nuclear Isotope Council outlines ambitious vision to double Canada’s isotope production by 2030
Toronto – March 29, 2023 – The Canadian Nuclear Isotope Council (CNIC) launched its new Isotopes for Hope campaign at the Empire Club of Canada with the goal of asserting and expanding Canada’s...
The Canadian Nuclear Isotope Council Announces its Incorporation as a Not-for-Profit Organization
Toronto – February 24, 2023 – The Canadian Nuclear Isotope Council (CNIC) is pleased to announce its recent accomplishment in achieving Not-for-Profit status. In collaboration with the CNIC’s new...
ACIC Pharmaceutical Machinery Inc. joins the CNIC to help Canadian companies bring radiopharmaceutical products “from Molecule to Market”
Toronto – February 7, 2023 – ACIC Pharmaceutical Machinery, a Canadian company located in Brantford, ON, is the newest member of the Canadian Nuclear Isotope Council (CNIC). ACIC Machinery provides...
ARC Clean Technology and the Canadian Nuclear Isotope Council partner to bolster Canada’s Isotope Ecosystem
Toronto – December 20, 2022 – The Canadian Nuclear Isotope Council (CNIC) is pleased to announce a partnership with ARC Clean Technology (ARC). As a member of the CNIC, ARC joins 76+ organizations...
Canadian Nuclear Isotope Council: Statement Regarding the Worldwide Isotope Shortage
Toronto – November 10, 2022 – There is mounting concern in Canada and around the world that a global medical isotope shortage of Molybdenum-99 (Mo-99) is impacting patients. As a result, doctors...
AtomVie Global Radiopharma Inc. joins the CNIC to bring new leadership, innovation, and collaboration to the radiopharmaceutical industry.
Toronto – November 2, 2022 – AtomVie Global Radiopharma Inc. (AtomVie), a manufacturer and supplier of multiple finished-dose therapeutic radiopharmaceutical products, is the newest member of the...
Isotope Production System at Bruce Power commences Commercial Production of Lutetium-177
Toronto, Ontario – October 25, 2022 – Yesterday, the international partnership between Bruce Power, Isogen (a Kinectrics and Framatome company), and ITM Isotope Technologies Munich (ITM), announced...
BWXT Medical Submits Tc-99m Generator New Drug Application to FDA
Company Highlights Growing Nuclear Medicine Product Portfolio and Future Opportunities in Therapeutic Radioisotopes (OTTAWA, ON – September 13, 2022) – BWX Technologies, Inc. (NYSE: BWXT) announced...
The CNIC joins twenty leading organizations as part of a joint Industry Statement touting the benefits of nuclear isotopes.
Toronto – August 16, 2022 – The Canadian Nuclear Isotope Council (CNIC) is proud to participate in a joint Industry Statement to the Tenth Review Conference of the Parties to the Treaty on the...
BWXT Medical and TRIUMF Execute Agreement for Manufacture of High Purity Ac-225 Based Products
(OTTAWA, ON – June 13, 2022) – BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. and TRIUMF, Canada’s particle accelerator centre, have executed a licensing and...
Job Posting: Policy, Government and Stakeholder Relations Specialist (Hybrid) – CLOSED
THIS POSITION IS NOW FILLED Job Overview Policy, Government and Stakeholder Relations Specialist at the CNIC is responsible for connecting federal, provincial, and municipal political leaders to the...
Laurentis is helping meet global demands by increasing He-3 production
Helium-3 (He-3) is a rare isotope used in research, border security and medical imaging In a world where raw materials and supplies are under tension, Helium-3 (He-3), a rare isotope used in quantum...
Installation complete of new Isotope Production System at Bruce Power, paving way for production of life-saving medical isotopes
TIVERTON, ON – January 24, 2022 – Bruce Power and Isogen (a partnership between Kinectrics and Framatome) have completed the installation of a groundbreaking Isotope Production System (IPS), making...
Laurentis Energy Partners signs long-term commercial agreement with Air Liquide for the distribution of Helium-3
Valuable isotope used in quantum computing, neutron research, border security and medical imaging Toronto, ON – Laurentis Energy Partners today announced a long-term commercial agreement with Air...
Regulatory approval supports Laurentis’s program to produce the medical isotope Molybdenum-99 in Ontario for BWXT Medical
One of the most prevalently used diagnostic imaging agents in nuclear medicine, helping to detect illnesses like cancer and heart disease Clarington, Ontario – A new program, led by Laurentis Energy...
Publications
Canada has a unique position that is recognized globally: it is the world’s largest supplier of Cobalt-60 and Iodine-125; it hosts mostly all supply chain partners within its borders; it has a long tradition in supply chain collaboration; and it is renowned around the world for developing new applications.
Securing Canadian Medical Isotope Talent & Expertise
CNIC report exploring challenges and solutions to hiring the correct talent during market growth
CNIC Fact Book
What is the Canadian Nuclear Isotope Council? Download our Fact Book to find out more.
Isotopes for Hope
Strengthening Canada’s Global Role in the Isotope Supply Chain to Double Production by 2030
Isotopes: Global Importance and Opportunities for Canada
This publication highlights the important of having a continuous and reliable supply of medical isotopes accessible to the rest of the world.
Introduction to CNIC
A glance at this independent organization and its role to advocate for Canada’s role in the production of the world’s supply of isotopes.
Did You Know?
The Canadian Nuclear Safety Commission licenses the use and production of over 250 radioisotopes in Canada. And more key facts. . . .